About Confluence discovery technologies

About company

Avoid Pitfalls Costly Delays Quality Research Partner from Idea to IND Our expert drug discovery scientists help meet milestones and expedite your timeline to reaching development candidate, Investigational New Drug (IND) and ultimately to market. Request Your Complimentary Consultation Now Full Service Drug Discovery Contract Research Organization (CRO) Confluence Discovery Technologies, Inc., an indirectly wholly owned subsidiary of Aclaris Therapeutics,…